Desk Report: The United States is implementing a tariff of up to 100 percent on imports of branded and patented pharmaceutical drugs from October 1. US President Donald Trump announced this on Thursday. India’s pharmaceutical industry, which is one of the most dependent on trade with the United States, may be significantly affected by this decision. Trump wrote on his own Truth Social, “Starting October 1, 2025, we will impose a 100 percent tariff on any branded or patented pharmaceutical product. If a company builds their pharmaceutical manufacturing plant in…
Read More